Mayel Gharanei

Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor

Mayel Gharanei, Afthab Hussain, Omar Janneh et al. · PLoS ONE · 2013 · 128 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Cell Death +18

Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore

Mayel Gharanei, Afthab Hussain, Omar Janneh et al. · Toxicology and Applied Pharmacology · 2012 · 54 citations · Full text

Mechanobiology, Inflammation, Cardiomyopathy +13

Caspase Inhibition Via A3 Adenosine Receptors: A New Cardioprotective Mechanism Against Myocardial Infarction

Afthab Hussain, Mayel Gharanei, Aarondeep Singh Nagra et al. · Cardiovascular Drugs and Therapy · 2013 · 33 citations · Full text

Cardiac Muscle, Heart Failure, Cardiovascular Disease +7

Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling

Mayel Gharanei, Sanam Shafaattalab, Sarabjit Sangha et al. · Methods · 2021 · 17 citations

Cardiac Muscle, Cardiomyopathy, Medicine +3

Investigation into the cardiotoxic effects of doxorubicin on contractile function and the protection afforded by cyclosporin A using the work-loop assay

Mayel Gharanei, Afthab Hussain, Rob S. James et al. · Toxicology in Vitro · 2014 · 14 citations · Full text

Inflammation, Medicinal Chemistry, Health Sciences +10